Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — November 2022

Genmab — November 2022

Planlagt Fastgjort Låst Flyttet Genmab
1.0k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • G Offline
    G Offline
    GeorgeBest
    wrote on sidst redigeret af
    #952

    Ny ATH, nice 🙂

    1 Reply Last reply
    0
    • concilladoC Offline
      concilladoC Offline
      concillado
      wrote on sidst redigeret af
      #953

      yeehaw! 🙂

      1 Reply Last reply
      0
      • S Offline
        S Offline
        Sukkeralf
        wrote on sidst redigeret af
        #954

        Hhhmmm hvad er der mon gang i?

        1 Reply Last reply
        0
        • G Offline
          G Offline
          GeorgeBest
          wrote on sidst redigeret af
          #955

          GEN1042 nyheder på torsdag???

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Sukkeralf
            wrote on sidst redigeret af
            #956

            Link Preview Image
            ESMO I-O 2022 - Online Programme - ESMO Immuno-Oncology Congress 2022

            favicon

            (cslide.ctimeetingtech.com)

            1 Reply Last reply
            0
            • S Offline
              S Offline
              Sukkeralf
              wrote on sidst redigeret af
              #957

              poster 175 - ja lad os håbe det er lovende data derfra

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #958

                After FDA Rejection, Spectrum Shelves Development On Poziotinib https://finance.yahoo.com/news/fda-rejection-spectrum-shelves-development-145947732.html ; potential amivantamab competitor, even though ami was deemed superior already https://www.clinicaltrialsarena.com/comment/janssens-amivantamab-has-competitive-edge-over-spectrums-and-takedas-exon-20-mutation-directed-tkis-in-nsclc/

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  ProinvestorNEWS
                  wrote on sidst redigeret af
                  #959

                  Genmab udvisker fald og går på rekordjagt https://www.proinvestor.com/investornyt/909356/genmab-udvisker-fald-og-gar-pa-rekordjagt-ny

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #960

                    GEN1053 TRIPLING the number of treatment centers !! ( form 1 to 3 😄 ) #newspaperheadlines https://clinicaltrials.gov/ct2/history/NCT05435339?A=4&B=5&C=merged#StudyPageTop

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #961

                      November 28
                      Genmab A/S (NASDAQ: GMAB) New Catalyst Idea of Morgan Stanley.Analyst Matt Harrison comments "What is thecatalyst? This arbitration flows from the result of the first arbitration that ruled in favor of J&J ... -i can't read the rest...

                      1 Reply Last reply
                      0
                      • G Offline
                        G Offline
                        gentogen
                        wrote on sidst redigeret af
                        #962

                        Once more well found! Interesting....

                        1 Reply Last reply
                        0
                        • T Offline
                          T Offline
                          Tommy_P.
                          wrote on sidst redigeret af
                          #963

                          Mange tak EL.

                          1 Reply Last reply
                          0
                          • StockBullS Offline
                            StockBullS Offline
                            StockBull
                            wrote on sidst redigeret af
                            #964

                            Morning. Betalings site https://www.streetinsider.com/Analyst+Comments/Genmab+AS+(GMAB)+New+Catalyst+Idea+of+Morgan+Stanley/20902723.html Morgan Stanley har lavt target og historien melder ikke om opjusteret target for så ville det have været på mange andre kendte sites

                            1 Reply Last reply
                            0
                            • Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktør
                              wrote on sidst redigeret af
                              #965

                              Godmorgen 🙂

                              1 Reply Last reply
                              0
                              • S Offline
                                S Offline
                                Stroka
                                wrote on sidst redigeret af
                                #966

                                God morgen 🙂

                                1 Reply Last reply
                                0
                                • G Offline
                                  G Offline
                                  GeorgeBest
                                  wrote on sidst redigeret af
                                  #967

                                  Vedr. 23:29 Morgan Stanley der jo er negative på Genmab forsøger, som jeg læser de 2 linier, at fortælle at da voldgiften er baseret på 1. ruling i JNJ favør, så har Genmab ringe chancer…PS jeg er ikke jurist så jeg aner ikke hvilken vej det går. Jeg har også valgt ikke at sætte store forhåbninger i voldgift nr. 2, for ikke at blive skuffet igen. Der er for mig at se nok andre katalysorer for en positiv Genmab udvikling

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    ProinvestorNEWS
                                    wrote on sidst redigeret af
                                    #968

                                    Tirsdagens aviser med Jyske Bank, SAS og Novo Nordisk https://www.proinvestor.com/investornyt/909592/tirsdagens-aviser-med-jyske-bank-sas-og-novo-nordisk

                                    1 Reply Last reply
                                    0
                                    • StockBullS Offline
                                      StockBullS Offline
                                      StockBull
                                      wrote on sidst redigeret af
                                      #969

                                      Link Preview Image
                                      Watching Genmab A/S; Hearing Oxford Momentum Newsletter Buys Stock - Genmab (NASDAQ:GMAB)

                                      favicon

                                      Benzinga (www.benzinga.com)

                                      1 Reply Last reply
                                      0
                                      • StockBullS Offline
                                        StockBullS Offline
                                        StockBull
                                        wrote on sidst redigeret af
                                        #970

                                        Link Preview Image
                                        Genmab Option Alert: May 19 $50 Calls at the Ask: 148 @ $4.1 vs 4 OI; Ref=$45.6 - Genmab (NASDAQ:GMAB)

                                        favicon

                                        Benzinga (www.benzinga.com)

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #971

                                          Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia https://www.frontiersin.org/articles/10.3389/fimmu.2022.1055473/full

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper